Dudediligence.

Mirum Pharmaceuticals, Inc

MIRMNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$90.4MSep ’24$99.4MDec ’24$111.6MMar ’25$127.8MJun ’25$133.0MSep ’25$148.9MDec ’25$159.9MMar ’26$176.2MJun ’26
Net income, by quarter
−$14.2MSep ’24−$23.8MDec ’24−$14.7MMar ’25−$5.9MJun ’25$2.9MSep ’25−$5.7MDec ’25−$790.2MMar ’26−$67.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$19.1M$77.1M$186.4M$336.9M$521.3M
Operating income−$173.4M−$131.2M−$109.2M−$87.6M−$22.1M
Net income−$84.0M−$135.7M−$163.4M−$87.9M−$23.4M
Operating cash flow−$132.8M−$120.1M−$70.9M$10.3M$55.8M
Free cash flow−$132.8M−$120.4M−$71.1M$9.3M$54.9M
Cash$31.3M$28.0M$286.3M$222.5M$296.7M
Shares outstanding30.6M37.0M46.7M48.3M51.9M